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OBJECTIVE—Lipocalin (LCN) 2 belongs to the lipocalin sub-
family of low–molecular mass–secreted proteins that bind small
hydrophobic molecules. LCN2 has been recently characterized as
an adipose-derived cytokine, and its expression is upregulated in
adipose tissue in genetically obese rodents. The objective of this
study was to investigate the role of LCN2 in diet-induced insulin
resistance and metabolic homeostasis in vivo.
RESEARCH DESIGN AND METHODS—Systemic insulin sen-
sitivity, adaptive thermogenesis, and serum metabolic and lipid
proﬁle were assessed in LCN2-deﬁcient mice fed a high-fat diet
(HFD) or regular chow diet.
RESULTS—The molecular disruption of LCN2 in mice resulted
in signiﬁcantly potentiated diet-induced obesity, dyslipidemia,
fatty liver disease, and insulin resistance. LCN2
/ mice exhibit
impaired adaptive thermogenesis and cold intolerance. Gene
expression patterns in white and brown adipose tissue, liver, and
muscle indicate that LCN2
/ mice have increased hepatic
gluconeogenesis, decreased mitochondrial oxidative capacity,
impaired lipid metabolism, and increased inﬂammatory state
under the HFD condition.
CONCLUSIONS—LCN2 has a novel role in adaptive thermoreg-
ulation and diet-induced insulin resistance. Diabetes 59:1376–
1385, 2010
O
besity is a major risk for developing insulin
resistance, a hallmark of type 2 diabetes and
other metabolic complications such as fatty
liver, dyslipidemia, and atherosclerosis. Adi-
pose tissue plays a central role in body weight homeosta-
sis, inﬂammation, and insulin resistance via regulating
lipid metabolism/storage and releasing a range of adipo-
kines/cytokines (1–4). Adipose tissue in a variety of insu-
lin-resistant states has been characterized by dysregulated
lipid metabolism and altered production of adipokines/
cytokines that, in sum, are important contributors to
systemic inﬂammation and related metabolic disorders.
Lipocalin (LCN) 2 (also known as neutrophil gelatinase–
associated lipocalin [NGAL]), a lipocalin subfamily mem-
ber, has been recently identiﬁed by our group and others
(5,6) as an adipose-derived cytokine. LCN2 is a 25-kDa
secreted protein initially identiﬁed from human neutro-
phils (7,8) and other immune cells and tissues that are
exposed to microorganisms in the respiratory and gastro-
intestinal tract and is present abundantly in the circulation
(9). Interestingly, lipocalins have structural similarity with
fatty acid binding proteins (FABPs), and both are mem-
bers of the multigene family of up and down -barrel
proteins (10). Both the intracellular FABPs and the extra-
cellular lipocalins have a clearly deﬁned -barrel motif
that forms either an interior cavity (FABP) or a deep pit
(lipocalins) that constitutes the lipid binding domain (10).
The extracellular lipocalins such as LCN2, retinol binding
protein (RBP) 4, and 2-microglobulin use a series of
-strands to form a globular domain with a deep depres-
sion resembling the calyx of a ﬂower. Because of the
unique structure, the lipocalins function as efﬁcient trans-
porters for a number of different hydrophobic ligands in
extracellular milieus, including a variety of retinoids, fatty
acids, biliverdin, pheromones, porphyrins, odorants, ste-
roids, and iron. RBP4, one of the extracellular lipocalins,
affects glucose metabolism and insulin sensitivity (11).
Previous studies have demonstrated that LCN2 gene
expression is upregulated in adipose tissue and liver of
genetically obese animals (6). Rosiglitazone administra-
tion signiﬁcantly reduces LCN2 expression in adipose
tissue in obese animals (6), suggesting that the protein
may function as a proinﬂammatory factor. Unexpectedly,
the addition of LCN2 protein to the culture media of
adipocytes and macrophages leads to the suppression of
tumor necrosis factor (TNF)- and lipopolysaccharide-
induced cytokine/chemokine production, indicating an
anti-inﬂammatory function (6). Most strikingly, LCN2 ap-
pears to protect against TNF-induced insulin resistance
in adipocytes. Unlike RBP4, increased production of LCN2
in obesity may be a protective mechanism against inﬂam-
mation and insulin resistance.
To evaluate this hypothesis, we assessed the metabolic
and regulatory consequences of LCN2 deﬁciency. Herein,
we show that the ablation of LCN2 profoundly impairs
adaptive thermogenesis and exacerbates high-fat diet
(HFD)- or age-induced insulin resistance and glucose
homeostasis. LCN2-deﬁcient mice have increased hepatic
gluconeogenesis and inﬂammatory state and exhibit a cold
sensitive phenotype.
RESEARCH DESIGN AND METHODS
LCN2
/ mice were kindly provided by Dr. Alan Aderem (Institute for
Systems Biology, Seattle, Washington), which were originally generated by Dr.
Shizuo Akira (Research Institute for Microbial Diseases, Osaka University,
Osaka, Japan). LCN2
/ mice were generated by gene targeting in embryonic
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into C57BL/6 blastocysts as described previously (12). C57BL/6 mice were
purchased from The Jackson Laboratory (Bar Harbor, ME). LCN2-null mice
were backcrossed onto the B6 background for 10 generations before mice
were used for the experiments. Heterozygous mating scheme was used to
generate wild-type and LCN2
/ mice for the experiments.
Aminals were housed in a speciﬁc pathegon-free facility at the University of
Minnesota. Animal handling followed the National Institutes of Health guidelines,
and experimental procedures were approved by the University of Minnesota
Animal Care and Use Committee. Age-matched male wild-type and LCN2
/mice
were allocated into groups (3–4 mice/cage) and fed an HFD (fat calories: 60%)
obtained from Bio-Serv (F3282; New Brunswick, NJ) or a regular chow diet
(RCD), with free access to water for all studies. In the adaptive thermogenesis
study, age-matched wild-type and LCN2
/mice on an RCD were exposed to 4°C,
with free acess to diet and water. Rectal temperature of the mice was measured
at the indicated time points using a MicroTherma Thermometer with rectal probe
for mice (Braintree Scientiﬁc, Braintree, MA).
Metabolic studies. During the experiemental period of HFD feeding, glucose
and insulin tolerance tests were conducted by the intraperitoneal injection of
glucose and insulin. Mice were fasted overnight (12 h) for the glucose
tolerance test (GTT) and for 6 h for insulin tolerance tests (ITTs). GTTs and
ITTs were conducted by intraperitoneal injection of glucose (1 mg/g body wt)
or insulin (0.75 units/kg body wt) with blood collection via the tail vein at 0,
15, 30, 60, 90, and 120 min. Blood glucose was measured using an Ascensia
glucometer.
Triglyceride content measurement. Lipid extraction was performed using
the Bligh-Dyer method (13). Brieﬂy, frozen liver tissue (100 mg) was homog-
enized in 1 ml water. Lipid was extracted using chloroform:methanol (2:1). An
aliquot of the organic phase was collected and dried with nitrogen and then
dissolved in isopropanol alcohol containing 1% Triton. Triglyceride content
was determined using commercially available kits (Stanbio Lab, reference no.
2150-1).
Primary mouse adipose cell isolation. Preparation of isolated adipose cells
from wild-type and LCN2
/ mice was performed as described previously
(14,15). After mincing, epididymal fat pads were digested with collagenase (2
mg/ml solution) in digestion vials containing Krebs-Ringer bicarbonate
HEPES buffer, pH 7.4; 200 nmol/l adenosine; and 3.5% BSA. After a 2-h
digestion, adipose cells were separated by centrifugation at 1,200 rpm for 10
min and washed twice with Krebs-Ringer bicarbonate HEPES buffer. After the
ﬁnal wash, adipose cells were collected for RNA extraction.
Adipose cell size analysis. Adipose tissue was obtained from the epididymal
and inguinal fat pad of wild-type and LCN2
/ mice fed an RCD. Tissue
samples (20–30 mg) were immediately ﬁxed in osmium tetroxide and incu-
bated in a water bath at 37°C for 48 h, as described previously (16), and then
adipose cell size was determined by a Beckman Coulter Multisizer III with a
400-m aperture. The range of cell sizes that can effectively be measured using
this aperture is 20–240 m. After collection of pulse sizes, the data were
expressed as particle diameters and displayed as histograms of counts against
diameter using linear bins and a linear scale for the x-axis. The ﬁgures were
generated using GraphPad Prism 5.01 for Windows (GraphPad Software, La
Jolla, CA).
Statistical analysis. Results were expressed as means  SE. Differences in
parameters between wild-type and LCN2
/ mice were evaluated using a
two-group t test with a 0.05 two-sided signiﬁcance level. A P value 0.05 was
considered signiﬁcant.
RESULTS
LCN2
/ mice are more susceptible to diet-induced
obesity. At 3 weeks of age, male wild-type and LCN2
/
mice were fed either an HFD for 12 weeks or RCD.
Throughout the experimental period, body weight was
signiﬁcantly different between wild-type and LCN2
/
mice fed an HFD (Fig. 1A) and RCD (Fig. 1B). LCN2
/
mice were signiﬁcantly heavier than wild-type mice on
either an HFD or RCD. The weight of white and brown fat
pads was signiﬁcantly higher in HFD-fed (Fig. 1C) or aged
LCN2
/ (Fig. 1D) mice than that in wild-type mice. Both
HFD-fed and aged LCN2
/ mice showed a signiﬁcantly
higher weight of liver, heart, kidney, and spleen (Fig. 1E
and F). Similar metabolic phenotypes were also observed
in female LCN2
/ mice (data not shown). However, the
overall growth did not appear to be signiﬁcantly affected,
as the body length and bone length (trabecular) were not
signiﬁcantly different between the genotypes (data not
shown). Figure 1G and H demonstrated the fat-cell size
distributions of wild-type and LCN2
/ mice on an RCD at
15 weeks of age, as measured by Multisizer analysis using
cells isolated from osmium-ﬁxed epididymal and inguinal
adipose tissue. The average peak diameter of the large-cell
population was signiﬁcantly larger for LCN2
/ mice
compared with wild-type mice, indicating that LCN2
/
adipose tissue contains larger adipose cells.
LCN2
/ mice display impaired adaptive thermogen-
esis. Because LCN2-deﬁcient mice gained more body
weight and increased adiposity, particularly when mice
were fed an HFD or aged, we examined food intake and
energy expenditure in LCN2
/ mice. An analysis of
indirect calorimetry measurements showed that food
intake, ambulatory activity, VO2, and RQ were not sig-
niﬁcantly different between RCD-fed wild-type and
LCN2
/ mice at 18 weeks of age (Fig. S1 in the online
appendix, available at http://diabetes.diabetesjournals.org/
cgi/content/full/db09–1735/DC1). We then assessed ther-
mogenic activity of brown adipose tissue (BAT) under
thermoneutral and thermal stress conditions. Body tem-
perature was measured in an ambient temperature of 28°C
and 22°C as well as during acute exposure to 4°C. Wild-
type and LCN2
/ mice at 12 weeks of age exhibited a
similar body temperature in an ambient temperature of
28°C (wild type, 38.34  0.34; LCN2
/, 38.2  0.30).
However, female LCN2
/ mice had a signiﬁcantly lower
rectal temperature than wild-type mice (Fig. 2A), while
male LCN2
/ mice had a trend toward decrease in rectal
temperature when kept in an ambient temperature of
22°C. More strikingly, LCN2
/ mice displayed cold sen-
sitivity and could not survive when exposed to 4°C for 10
h. LCN2
/ mice (seven of seven) died after being ex-
posed to 4°C for 12 h, while all of the wild-type mice (n 
7) in the experiment survived. When acutely exposed to
4°C, rectal temperature of LCN2
/ mice dropped signif-
icantly within 3 h compared with wild-type mice (Fig. 2B).
Five-hour cold exposure caused a 10-fold increase in
LCN2 gene expression in adipose tissue in wild-type mice
(Fig. 2C), suggesting that LCN2 is a critical regulator of
energy metabolism.
To explore the possible mechanisms for cold intoler-
ance in LCN2
/ mice, uncoupling protein (UCP)-1–medi-
ated thermogenic activity and capacity of BAT was ﬁrst
evaluated under the conditions of HFD feeding and cold
exposure. We observed that upon HFD feeding, LCN2
/
mice expressed signiﬁcantly lower levels of UCP-1 and
peroxisome proliferator–activated receptor (PPAR) 	 co-
activator (PGC-1) genes in BAT than wild-type mice mice
(Fig. 2D). However, UCP-1 and PGC-1 expression in BAT
were markedly stimulated at an even higher level in
LCN2
/ mice, as wild-type mice after exposure to 4°C for
5 h (Fig. 2E). This suggests that LCN2
/ BAT remains at
normal UCP-1–dependent thermogenic activity. We next
examined whether the regulation of substrate provision is
altered in LCN2
/ mice. Figure 2F showed that the
protein expression levels of adipose triglyceride lipase
(ATGL) in white adipose tissue (WAT) were slightly re-
duced in LCN2
/ mice under the HFD and cold condition
compared with wild-type mice. However, cold-induced
HSL gene expression in BAT and WAT was completely
diminished in LCN2
/ mice (Fig. 2G). Lastly, we investi-
gated the mitochondrial oxidative capacity of BAT, as this
function of BAT is critical for providing the energy for
thermogenesis. Interestingly, we observed that there
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mitochondrial genes involved in mitochondrial biogen-
esis and oxidative function, such as nuclear respiratory
factor (Nrf)1, transcription factor A, mitochondrial (Tfam),
ATP synthase 5 (ATP5), cytochrome c oxidase (COX)4 ,
and carnitine palmitoyltransferase (CPT)-1 in BAT of
LCN2
/ mice fed an HFD (Fig. 2H). In addition, the
expression of transcription factors PPAR, Nrf1 and Tfam,
and CPT-1 gene in skeletal muscle was also signiﬁcantly
downregulated in LCN2
/ mice fed an HFD (Fig. 2D).
LCN2
/ mice develop more severe diet-induced in-
sulin resistance and increased inﬂammatory state.
To assess the effects of LCN2 deﬁciency on systemic
insulin sensitivity, GTTs and ITTs were performed. Glu-
cose clearance curves in response to glucose administra-
tion were signiﬁcantly increased in HFD-fed (Fig. 3A) but
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FIG. 1. Growth curve, weight of white and brown fat pads and organs in LCN2
/ mice. Growth curve of LCN2
/ mice on an HFD (n  10–14)
(A) and RCD (n  13) (B). Fat pad weight of LCN2
/ mice on an HFD at 16 weeks of age (C) and on RCD at 30 weeks of age (D). Organ weight
of LCN2
/ mice on HFD at 16 weeks of age (E) and on RCD at 30 weeks of age (F). The data are represented as mean  SE. *P < 0.05; **P <
0.01. Fat-cell size distribution of mice on RCD diet at 15 weeks of age (G and H). EPI: epididymal; ING: inguinal.
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/ mice (Fig. 3B), indicating that
LCN2
/ mice are more glucose intolerant upon HFD
feeding. In the ITT, increased insulin-stimulated glucose
disposal curve was observed in LCN2
/ mice, indicating
that LCN2
/ mice are more insulin resistant than wild-
type controls when fed an HFD (Fig. 3C) or aged (Fig. 3D).
Analysis of serum metabolic parameters, as shown in
Table 1, demonstrated that levels of fasting serum glucose
and insulin were signiﬁcantly elevated, while adiponectin
levels were reduced in HFD-fed LCN2
/ mice when
compared with wild-type controls. Serum levels of leptin
and plasminogen activator inhibitor-1 were not signiﬁ-
cantly changed in LCN2
/ mice on an RCD, although
serum leptin levels had a trend toward a decrease in
HFD-fed LCN2
/ mice. After adjustment to body weight,
the serum levels of glucose, insulin, and adiponectin were
consistently different at the statistically signiﬁcant level,
indicating that the changes in glucose tolerance and
insulin sensitivity after HFD in LCN2
/ mice is not simply
due to body weight effects. To further conﬁrm that
LCN2
/ mice have decreased insulin sensitivity, in vivo
insulin-stimulated Akt phosphorylation was evaluated.
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TABLE 1
Serum metabolic parameters in wild-type and LCN2
/ mice
Genotype Diet
Glucose
(mg/ml)
Insulin
(ng/ml)
Leptin
(ng/ml)
Adiponectin
(g/ml)
Plasminogen
activator
inhibitor-1
(ng/ml)
Wild type RCD 82.33  3.27 0.56  0.15 3.33  1.56 14.78  1.85 3.59  0.51
LCN2
/ RCD 100.38  4.99* 0.79  0.11 3.06  0.95 15.46  1.02 3.22  0.62
Wild type HFD 157.10  19.55 1.85  0.36 24.23  3.86 16.50  0.34 2.83  0.42
LCN2
/ HFD 238.13  6.45† 3.02  0.57† 16.62  2.07 13.50  0.88† 3.43  0.79
Data are means  SE. Measurements were performed on 6-h–fasted mice fed an RCD and HFD (n  9–11). *P  0.01 vs. wild-type on an
RCD; †P  0.01 vs. wild-type on an HFD.
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/ mice on RCD were injected intra-
peritoneally with insulin, killed after 10 min, and tissues
were collected for evaluation of Akt phosohorylation.
Consistently, insulin-stimulated Akt phosphorylation in
liver, muscle, and adipose cells was signiﬁcantly reduced
in LCN2
/ mice as compared with wild-type mice (Fig.
4). The examination of LCN2 effect on upstream signaling
components of insulin signaling pathway demonstrated
that the expression levels of insulin receptor substrate-1
protein were markedly reduced in WAT of LCN2
/ mice
on an HFD compared with wild-type mice (Fig. S2). This
data further support that LCN2
/ mice developed more
insulin resistance and LCN2 regulates insulin signaling
activity likely at the upstream level.
To test the role of LCN2 in inﬂammatory response,
expression of LCN2 and inﬂammatory molecules was
examined in adipose tissue and liver of HFD-induced
wild-type and LCN2
/ mice. The protein expression levels
of LCN2 were decreased in adipose tissue (Fig. 5A) and bone
marrow–derived macrophages of normal mice upon an HFD
feeding (Fig. 5B). Furthermore, the gene expression of proin-
ﬂammatory cytokine TNF and monocyte chemoattractant
protein (MCP)-1 were upregulated, while expression of argi-
nase 1, an anti-inﬂammatory marker, was downregulated in
adipose tissue of HFD-fed LCN2
/ mice compared with
wild-type control mice (Fig. 5C). Downregulation of arginase
1 and interleukin (IL)-10 was also observed in the liver of
HFD-fed LCN2
/ mice (Fig. 5C).
LCN2
/ mice develop dyslipidemia and fatty liver.
To investigate whether increased liver weight in LCN2
/
mice is associated with the development of fatty liver and
dyslipidemia, liver triglyceride content and blood lipid
proﬁles were measured. In comparison with wild-type
controls, HFD-fed and aged LCN2
/ mice demonstrated a
signiﬁcant increase in lipid accumulation as detected by
oil-red o staining of the liver section (Fig. 6A) and the
increased levels of liver triglycerides (Fig. 6B). The devel-
opment of more severe fatty liver disease, together with
elevated fasting blood glucose levels, suggests hepatic
insulin resistance in LCN2
/ mice. To elucidate hepatic
glucose production in wild-type and LCN2-deﬁcient mice
fed an HFD, mice were fasted for 18 h and gene expression
of two key gluconeogenic enzymes PEPCK and glucose-6-
phosphatase (G6Pase) were detected by quantitative PCR.
As illustrated in Fig. 6C, expression levels of PEPCK1,
PEPCK2, and G6Pase genes were signiﬁcantly higher in
the liver of LCN2
/ mice than that in wild-type controls,
suggesting that increased hepatic glucose production is
attributed to hyperglycemia in LCN2
/ mice. We next
examined the hepatic capabilities for fatty acid synthesis
and oxidation to explore the possible mechanism for the
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FIG. 4. In vivo insulin-stimulated Akt phosphorylation in LCN2
/
mice. Representative Western blot analysis of serine-phosphorylated
Akt in muscle, liver, and isolated primary adipose cells from LCN2
/
(n  4 per group) and wild-type mice (n  4 per group) under basal and
in vivo insulin-stimulated conditions.
RCD HFD
WAT A
LCN2
β-ac
RCD HFD RCD HFD
LCN2+/+ LCN2-/-
β-ac
LCN2
B BM-MAC
0
1
2
3
4
5
6
7
8
9
10
TNFα MCP-1 Arginase 1 MCP-1 Arginase 1 IL-10
WAT iver
T
a
r
g
e
t
 
g
e
n
e
/
a
c
t
i
n
 
(
A
U
)
LCN2+/+
LCN2-/-
C
*
* * *
L
FIG. 5. Protein expression levels of LCN2 and gene expression of
proinﬂammatory molecules in LCN2
/ mice. A: Protein expression
levels of LCN2 in adipose tissues of wild-type mice fed an RCD and
HFD. B: Protein expression levels of LCN2 in bone marrow macro-
phages (BM-MAC) isolated from wild-type mice fed an RCD and HFD.
C: Gene expression of inﬂammatory molecules in adipose tissue and
liver of wild-type and LCN2
/ mice fed on HFD. The data of gene
expression are represented as means  SE. *P < 0.05.
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/ mice. As illustrated
in Fig. 6D, the lipogenic genes sterol regulatory element-
binding protein-1c (SREBP-1c), acetyl-CoA carboxylase 1
(ACC1), Spot 14 (S14), and SCD-1 were expressed at a
signiﬁcantly higher level in HFD-fed LCN2
/ mice com-
pared with wild-type controls, while genes involved in
fatty acid oxidation such as PPAR, CPT-1, and acetyl-CoA
carboxylase 2 were similarly expressed between geno-
types (data not shown). Therefore, the development of
fatty liver results primarily from the increased capability
for fatty acid synthesis in the liver in LCN2
/ mice.
Blood lipid proﬁles are summarized in Table 2. Com-
pared with wild-type mice, LCN2
/ mice on an RCD
had signiﬁcantly higher serum levels of triglycerides, cho-
lesterol, and free fatty acids. The HFD feeding did not
induce a further increase in serum levels of triglyceride
and cholesterol but signiﬁcantly augmented the levels of
LDL and -hydroxybutyrate in LCN2
/ mice compared
with wild-type controls. The above data have suggested
that LCN2-deﬁcient mice became more insulin resistant
upon HFD feeding and age. Since adipose tissue is a key
site for insulin-regulated glucose/lipid metabolism and
glucose disposal, we examined the expression of genes
involved
in lipid metabolism in primary adipose cells isolated
from LCN2
/ mice. Compared with wild-type adipose
cells, expression levels of genes involved lipid metabolism
and adipokines, including PPAR, lipoprotein lipase
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FIG. 6. Liver triacyglyceride content in LCN2
/ mice. A: Oil-red O staining of liver section of LCN2
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TABLE 2
Plasma lipid proﬁle in wild-type and LCN2-null mice
Genotype Diet
Triglycerides
(mg/dl)
Cholesterol
(mg/dl)
HDL direct
(mg/dl)
LDL direct
(mg/dl)
Nonesteriﬁed
fatty acids
(mEq/l)
-Hydroxybutyrate
(mmol/l)
Wild type RCD 89.76  3.39 168.14  5.56 85.26  3.59 7.07  0.29 1.31  0.03 0.36  0.03
LCN2
/ RCD 100.07  4.05 191.82  6.17* 94.99  4.75 6.71  0.38 1.58  0.07 0.27  0.05
Wild type HFD 110.23  3.34 194.72  4.59 90.5  2.23 6.74  0.33 1.23  0.07 0.39  0.04
LCN2
/ HFD 99.34  1.78 197.26  14.82 86.63  2.79 17.38  3.19† 1.11  0.04 0.48  0.02†
Data are means  SE. Measurements were performed on 6-h–fasted mice fed an RCD and HFD (n  9–11). *P  0.01 vs. wild-type on an
RCD; †P  0.01 vs. wild-type on an HFD.
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reduced in adipose tissue of HFD-fed LCN2
/ mice
(online appendix Fig. S2).
DISCUSSION
We show here that LCN2 plays a critical role in lipid
metabolism, adaptive thermoregulation, and diet-induced
obesity and insulin resistance in vivo. Lack of LCN2 in
mice potentiates HFD-induced obesity, dyslipidemia, fatty
liver, glucose intolerance, and insulin resistance. We also
discovered that LCN2 is a critical regulator of adaptive
thermogenesis and mitochondrial oxidative function in
BAT. LCN2 deﬁciency impairs adaptive thermogenesis and
increases the susceptibility of LCN2
/ mice to HFD-
induced obesity.
Our data demonstrated that LCN2
/ mice gained more
body weight when they were fed HFD or aged. Increased
body fat mass together with enlarged multiple organs may
contribute to the development of higher body weight in
LCN2
/ mice. In particular, increased organ weights may
largely account for increased body weight in LCN2
/
mice under the RCD condition. In general, wild-type and
LCN2
/ mice at a young age did not demonstrate signif-
icantly different metabolic phenotypes when they were fed
RCD. However, LCN2
/ mice developed more severe
systemic insulin resistance, hyperglycemia, hyperinsulin-
emia, and hypoadiponectinemia under the HFD condition.
One of the most profound phenotypic features of LCN2
/
mice is cold sensitivity and lower body temperature under
thermal stress conditions. It has been known for a long
time that nonshivering thermogenesis is used to maintain
constant body temperature and energy balance, control-
ling body weight, especially in small mammals (17–19).
Both neural and hormonal signals, including norepineph-
rine, epinephrine, thyroid hormones, glucagon, insulin,
glucocorticoid, and leptin, are known to regulate thermo-
genesis (17,20) through different thermogenic mechanisms
involving stimulating ATP utilization, increasing UCP-1–
mediated proton leak and heat production and affecting
substrate availability and utilization for energy production.
In rodents, BAT is the main tissue that is responsible for
sympathetic nervous system–regulated nonshivering the-
mogenesis with the involvement of norepinephrine and
epinephrine (17,20,21). UCP-1 and PGC-1 are the key
genes that mediate sympathetic thermogenic responses in
BAT. Low sympathetic activity is known to be associated
with obesity (22). For example, UCP-1 gene expression in
BAT of ob/ob mice was reduced (23). However, BAT
UCP-1 expression could be normally stimulated in re-
sponse to cold environment in young ob/ob mice, albeit
ob/ob mice show decreased capability of utilizing fat and
cold intolerance (23).
In this study, we found that 5-h cold exposure leads to a
signiﬁcant increase in LCN2 expression in WAT, which is
in agreement with the result in a recent study (24). In the
absence of LCN2, mice were cold intolerant and failed to
maintain the body temperature when acutely exposed to
cold temperature. Interestingly, cold exposure could still
signiﬁcantly stimulate gene expression of UCP-1 and
PGC-1 in BAT in LCN2
/ mice, suggesting that cold-
induced sympathetic thermogenesis remained intact in the
absence of LCN2. The role of leptin in thermogenesis has
been well documented, and its thermogenic effect is
considered to be primarily central (25). The peripheral
role of leptin in thermogenesis is controversial. For exam-
ple, leptin administration has been reported to rescue
cold-induced hypothermia in the absence of UCP-1 in
leptin and UCP-1 double knockout mice (26,27), while the
opposite results were perceived in the other two indepen-
dent studies (28,29). In LCN2
/ mice on RCD, serum
leptin levels were not different from that in wild-type mice,
albeit serum leptin levels had a trend toward decreased in
LCN2
/ mice in response to HFD feeding. Additionally,
wild-type and LCN2
/ mice on an RCD did not exhibit a
difference in body temperature in thermoneutral condi-
tions. Our results suggest that the central control of body
temperature may function normally. Therefore, it seems
rather unlikely that leptin could be the major contributor
to cold intolerance in LCN2
/ mice; leptin may be only
partially involved in LCN2-regulated thermogenesis.
In addition to hormonal signals, defects in key meta-
bolic regulators of substrate availability for energy produc-
tion, ATP synthesis and mitochondrial biogenesis and
oxidative function could all possibly affect thermogenic
function. Indeed, studies in mice with the genetic disrup-
tion of key metabolic regulators have proved this assump-
tion; mice without expressing ATGL could similarly result
in cold intolerance (30). In the present study, the disrup-
tion of LCN2 completely diminished cold-induced HSL
gene expression in BAT and WAT, whereas ATGL expres-
sion in WAT was only slightly affected in LCN2
/ mice
under both the HFD and cold conditions. Since HSL
/
mice are not cold sensitive (31), HSL is not an important
regulator for adaptive thermogenesis. Therefore, the effect
of changes in ATGL levels on the supply of substrates for
energy production for thermogenesis is minimal in
LCN2
/ mice. On the other hand, the production of the
energy necessary for thermogenesis requires normal mito-
chondrial oxidative function, and mitochondrial dysfunc-
tion could have a signiﬁcant impact on adaptive
thermogenesis. This hypothesis has been supported by a
previous study in estrogen-related receptor  (EER)
knockout mice. In EER-deﬁcient mice, mitochondrial
biogenesis and oxidative function in BAT was disturbed,
and mice failed to maintain body temperature when ex-
posed to cold (32). To this end, we further investigated the
mitochondrial oxidative capacity of BAT and skeletal
muscle. Interestingly, we found that the expression levels
of mitochondrial genes involved in mitochondrial biogen-
esis and oxidative function such as Nrf1, Tfam, ATP5b,
COX 4, and CPT-1 were signiﬁcantly reduced in BAT of
LCN2
/ mice fed an HFD. In the skeletal muscle, the
expression of -oxidation genes PPAR and CPT-1, as well
as mitochondrial genes Nrf1 and Tfam, were also down-
regulated in HFD-fed LCN2
/ mice.
All the above data together suggest that mitochondrial
metabolism is dysfunctional in BAT and muscle of
LCN2
/ mice, which mainly contributes to decreased
thermogenic capacity, decreased energy expenditure, and
the high susceptibility to diet-induced obesity and insulin
resistance during the thermal stress conditions (mice have
been living at 22°C). In acute cold, muscle-shivering ther-
mogenesis is considered to be the primary mechanism for
a body temperature defense (21,33,34). BAT nonshivering
thermogenesis participates in combating the cold temper-
ature only when the extra capacity is already recruited for
using during the acute cold exposure (35). Therefore, cold
intolerance (acute exposure to 4°C for 5 h) in LCN2
/
mice may largely result from decreased oxidative capacity
in skeletal muscle and BAT as well as decreased ATGL
expression in WAT.
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siveness in muscle, adipose tissue, and liver was reduced,
indicating systemic insulin resistance in LCN2
/ mice.
Furthermore, fasting for 18 h induces signiﬁcantly higher
levels of expression for PEPCK and G6Pase in the liver of
HFD-fed LCN2
/ mice, supporting that the increased
hepatic glucose production is an important contributor to
fasting hyperglycemia in LCN2
/ mice. Dyslipidemia
such as hypertriacylglycerolemia and hypercholesterol-
emia is another prominent feature perceived in LCN2
/
mice. This phenomenon is likely due to the impaired
regulation of lipid metabolism in adipose tissue and liver
in LCN2
/ mice. We showed that LCN2
/ mice on an
RCD had higher serum levels of triglycerides but lower
serum triglyceride levels when fed an HFD as compared
with wild-type mice. Lower serum triglycerides in HFD-fed
LCN2
/ mice could be due to the increased triglycerides
synthesis and decreased VLDL (or triglyceride) secretion
into the circulation resulting from the development of fatty
liver in LCN2
/ mice. This explanation is strengthened by
a previous study (36) in LIRKO (insulin receptor knock-
out) mice with hepatic insulin resistance and 50% decrease
in serum triglyceride levels.
As reported in our previous in vitro study (6), LCN2 is
capable of suppressing inﬂammatory response of macro-
phages to LPS stimulation. We speculated that LCN2
possesses anti-inﬂammatory role in metabolic regulation.
In this in vivo study, we show that LCN2 expression is
downregulated in adipose tissue and bone marrow macro-
phages (BM-MAC) in HFD-induced obese mice. In the
absence of LCN2, the expression of proinﬂammatory cy-
tokines such as MCP-1 and TNF are upregulated in
adipose tissue, while expression levels of anti-inﬂamma-
tory markers arginase 1 and IL-10 are decreased in adipose
tissue and liver, suggesting an increased inﬂammatory
state in LCN2
/ mice. These results further suggest that
LCN2
/ mice are more susceptible to HFD-induced
proinﬂammatory response than wild-type mice.
In summary, herein we discovered a novel role for LCN2
in energy metabolism, adaptive thermogenesis, and insulin
resistance. Mice lacking LCN2 display impaired adaptive
thermogenesis and deteriorated diet-induced obesity and
insulin resistance. Decreased mitochondrial oxidative ca-
pacity in BAT and skeletal muscle may be the primary
mechanisms for the development of diet-induced insulin
resistance and cold sensitive in LCN2
/ mice. However,
the mechanisms for how LCN2 regulates mitochondrial
function and lipid metabolism remain to be further iden-
tiﬁed. It is likely that the binding of LCN2 to small
hydrophobic molecules such as retinoic acids, fatty acids,
and other unknown ligands or to the cell surface receptor
such as megalin or LDL-related protein 2 (37) could
potentially involve or mediate LCN2 effects in metabolism.
Our ﬁndings provide new insight into the role of LCN2 in
lipid metabolism and metabolic homeostasis. In this man-
ner, LCN2 may be a potential therapeutic target for
controlling obesity-associated type 2 diabetes and meta-
bolic complications.
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